Created by Invesco on Jun 23, 2005. The Invesco Dynamic Biotechnology & Genome ETF seeks to track the Dynamic Biotech & Genome Intellidex Index.
The ETF's annual expense ratio amounts to 0.58 %. The ETF replicates the performance of the underlying index by full replication (buying all the index constituents). The dividends in the ETF are distributed to the investors quarterly with an annual yield of 0.99 %.
The Invesco Dynamic Biotechnology & Genome ETF is a Medium (100 - 500M) ETF with $ 260.4 M assets under management. It's domiciled in United States.
